Transforming Growth Factor-β: Transforming Plaque to Stability

Overview

Journal Eur Heart J

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2012 Jul 31

PMID 22843445

Citations 5

Authors

Kevin Tse

Klaus Ley

Affiliations

Soon will be listed here.

Citing Articles

Cancer-associated foam cells hamper protective T cell immunity and favor tumor progression in human colon carcinogenesis.

Daveri E, Vergani B, Lalli L, Ferrero G, Casiraghi E, Cova A J Immunother Cancer. 2024; 12(10).

PMID: 39395839 PMC: 11474856. DOI: 10.1136/jitc-2024-009720.

Macrophages use apoptotic cell-derived methionine and DNMT3A during efferocytosis to promote tissue resolution.

Ampomah P, Cai B, Sukka S, Gerlach B, Yurdagul Jr A, Wang X Nat Metab. 2022; 4(4):444-457.

PMID: 35361955 PMC: 9050866. DOI: 10.1038/s42255-022-00551-7.

Galectin-3 Identifies a Subset of Macrophages With a Potential Beneficial Role in Atherosclerosis.

Di Gregoli K, Somerville M, Bianco R, Thomas A, Frankow A, Newby A Arterioscler Thromb Vasc Biol. 2020; 40(6):1491-1509.

PMID: 32295421 PMC: 7253188. DOI: 10.1161/ATVBAHA.120.314252.

Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.

Tse K, Gonen A, Sidney J, Ouyang H, Witztum J, Sette A Front Immunol. 2014; 4:493.

PMID: 24416033 PMC: 3873602. DOI: 10.3389/fimmu.2013.00493.

T cells in atherosclerosis.

Tse K, Tse H, Sidney J, Sette A, Ley K Int Immunol. 2013; 25(11):615-22.

PMID: 24154816 PMC: 3806170. DOI: 10.1093/intimm/dxt043.

References

Bobik A . Transforming growth factor-betas and vascular disorders. Arterioscler Thromb Vasc Biol. 2006; 26(8):1712-20. DOI: 10.1161/01.ATV.0000225287.20034.2c. View

Sarzani R, Brecher P, CHOBANIAN A . Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest. 1989; 83(4):1404-8. PMC: 303835. DOI: 10.1172/JCI114029. View

Grainger D, Kemp P, Metcalfe J, Liu A, Lawn R, Williams N . The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med. 1995; 1(1):74-9. DOI: 10.1038/nm0195-74. View

Stefoni S, Cianciolo G, Donati G, Dormi A, Silvestri M, Coli L . Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int. 2002; 61(1):324-35. DOI: 10.1046/j.1523-1755.2002.00119.x. View

Choi J, Cheong C, Dandamudi D, Park C, Rodriguez A, Mehandru S . Flt3 signaling-dependent dendritic cells protect against atherosclerosis. Immunity. 2011; 35(5):819-31. DOI: 10.1016/j.immuni.2011.09.014. View

McCaffrey T, DU B, Fu C, Bray P, Sanborn T, Deutsch E . The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. J Mol Cell Cardiol. 1999; 31(9):1627-42. DOI: 10.1006/jmcc.1999.0999. View

Lievens D, Habets K, Robertson A, Laouar Y, Winkels H, Rademakers T . Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis. Eur Heart J. 2012; 34(48):3717-27. PMC: 3869966. DOI: 10.1093/eurheartj/ehs106. View

Tashiro H, Shimokawa H, Sadamatu K, Yamamoto K . Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease. Coron Artery Dis. 2002; 13(3):139-43. DOI: 10.1097/00019501-200205000-00001. View

Frutkin A, Otsuka G, Stempien-Otero A, Sesti C, Du L, Jaffe M . TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2009; 29(9):1251-7. PMC: 2740721. DOI: 10.1161/ATVBAHA.109.186593. View

10.

Robertson A, Rudling M, Zhou X, Gorelik L, Flavell R, Hansson G . Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest. 2003; 112(9):1342-50. PMC: 228445. DOI: 10.1172/JCI18607. View

11.

Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, Merval R . Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res. 2001; 89(10):930-4. DOI: 10.1161/hh2201.099415. View

12.

Gojova A, Brun V, Esposito B, Cottrez F, Gourdy P, Ardouin P . Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood. 2003; 102(12):4052-8. DOI: 10.1182/blood-2003-05-1729. View

13.

Ovchinnikova O, Robertson A, Wagsater D, Folco E, Hyry M, Myllyharju J . T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice. Am J Pathol. 2009; 174(2):693-700. PMC: 2630576. DOI: 10.2353/ajpath.2009.080561. View

14.

Laouar Y, Sutterwala F, Gorelik L, Flavell R . Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol. 2005; 6(6):600-7. DOI: 10.1038/ni1197. View

15.

Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky V . Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol. 2002; 22(6):975-82. DOI: 10.1161/01.atv.0000019729.39500.2f. View

16.

von Vietinghoff S, Ley K . Interleukin 17 in vascular inflammation. Cytokine Growth Factor Rev. 2010; 21(6):463-9. PMC: 3005323. DOI: 10.1016/j.cytogfr.2010.10.003. View